News Wrap: FDA head Marty Makary resigning after uneven tenure
What this video covers
This is the PBS NewsHour’s evening news wrap for Tuesday, May 12, 2026 — the day Dr. Marty Makary’s resignation as FDA Commissioner was announced. The Makary story leads a segment that also covers UK Prime Minister Keir Starmer’s refusal to resign under party pressure and FBI Director Kash Patel’s pushback against allegations of on-the-job drinking.
The NewsHour’s headline framing — “resigning after uneven tenure” — sets the tone: this is the establishment newsroom’s verdict on a fourteen-month commissionership that began with reformist promise and ended in a politically bruising exit. By the time of this broadcast, the broad outlines were in place: reports of White House pressure on flavored-vape authorizations, a weekslong campaign from anti-abortion activists over mifepristone, and earlier reporting that Trump had signed off on a plan to fire Makary.
The segment is a news summary, not an investigation — a seven-minute wrap of the day’s developments. It captures the mainstream framing of the resignation at the moment it happened: a failed tenure at a destabilized agency, with Kyle Diamantas stepping in as acting commissioner.
Key points
- PBS NewsHour led its May 12, 2026 news wrap with Makary’s resignation, characterizing his tenure as “uneven.”
- The segment treats the resignation as the culmination of reported White House pressure, including the flavored-vape authorization dispute and the mifepristone pressure campaign.
- By broadcast time, reporting had already established that Trump had reportedly approved plans to replace Makary before the resignation went public.
- Kyle Diamantas, FDA Deputy Commissioner for Human Foods, was named as acting head — the transition the administration presented as orderly.
- The framing contrasts with Makary’s defenders, who cast the exit as principled resistance to politically driven approvals; the NewsHour’s version reads it as a management failure.